138 related articles for article (PubMed ID: 2536882)
21. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
Koike H; Imanishi N; Natsume Y; Morooka S
Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics.
Homma H; Hanahan DJ
Arch Biochem Biophys; 1988 Apr; 262(1):32-9. PubMed ID: 2833174
[TBL] [Abstract][Full Text] [Related]
23. Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells.
Kester M; Thomas CP; Wang J; Dunn MJ
J Cell Physiol; 1992 Nov; 153(2):244-55. PubMed ID: 1331121
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of platelet-activating factor responsiveness during maturation of human dendritic cells.
Dichmann S; Rheinen H; Panther E; Herouy Y; Czech W; Termeer C; Simon JC; Gebicke-Haerter PJ; Norgauer J
J Cell Physiol; 2000 Dec; 185(3):394-400. PubMed ID: 11056009
[TBL] [Abstract][Full Text] [Related]
25. Autocrine stimulation of B lymphocytes by a platelet-activating factor receptor agonist, 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine.
Tordai A; Franklin RA; Johnson C; Mazer BD; Clay KL; Gelfand EW
J Immunol; 1994 Jan; 152(2):566-73. PubMed ID: 8283038
[TBL] [Abstract][Full Text] [Related]
26. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia.
Donnard M; Guglielmi L; Turlure P; Piguet C; Couraud MJ; Bordessoule D; Denizot Y
Stem Cells; 2002; 20(5):394-401. PubMed ID: 12351810
[TBL] [Abstract][Full Text] [Related]
27. 1,25-(OH)2 vitamin D-3 enhances Paf-stimulated calcium mobilization in U937 cells by expression of specific Paf binding sites.
Aepfelbacher M; Korth R; Weber PC
Biochim Biophys Acta; 1990 Feb; 1051(2):179-84. PubMed ID: 2155666
[TBL] [Abstract][Full Text] [Related]
28. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C.
Yue TL; Stadel JM; Sarau HM; Friedman E; Gu JL; Powers DA; Gleason MM; Feuerstein G; Wang HY
Mol Pharmacol; 1992 Feb; 41(2):281-9. PubMed ID: 1311408
[TBL] [Abstract][Full Text] [Related]
29. Possible existence of two subsets of platelet-activating factor receptor to mediate polyphosphoinositide breakdown and calcium influx in neuroblastoma x glioma hybrid NG 108-15 cells.
Chau LY; Hu CY; Chang WT; Hsu YS
J Neurochem; 1992 Sep; 59(3):1090-8. PubMed ID: 1322966
[TBL] [Abstract][Full Text] [Related]
30. Inositol phospholipid turnover in PAF transmembrane signalling.
Shukla SD
Lipids; 1991 Dec; 26(12):1028-33. PubMed ID: 1668102
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.
Stewart AG; Grigoriadis G
J Lipid Mediat; 1991 Nov; 4(3):299-308. PubMed ID: 1662547
[TBL] [Abstract][Full Text] [Related]
32. RGS4 inhibits platelet-activating factor receptor phosphorylation and cellular responses.
Richardson RM; Marjoram RJ; Barr AJ; Snyderman R
Biochemistry; 2001 Mar; 40(12):3583-8. PubMed ID: 11297424
[TBL] [Abstract][Full Text] [Related]
33. Specific binding of platelet-activating factor (PAF) by human peripheral blood mononuclear leukocytes.
Ng DS; Wong K
Biochem Biophys Res Commun; 1988 Aug; 155(1):311-6. PubMed ID: 2843182
[TBL] [Abstract][Full Text] [Related]
34. Similar coronary vascular effects in the rat perfused heart of platelet-activating factor structural analogues with agonist and antagonist properties.
Man RY; Kinnaird AA
Br J Pharmacol; 1995 Nov; 116(5):2359-64. PubMed ID: 8581269
[TBL] [Abstract][Full Text] [Related]
35. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil.
Triggiani M; Goldman DW; Chilton FH
Biochim Biophys Acta; 1991 Jun; 1084(1):41-7. PubMed ID: 1647203
[TBL] [Abstract][Full Text] [Related]
36. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
[TBL] [Abstract][Full Text] [Related]
37. Platelet-activating factor-induced intracellular signaling and release of cytokines and prostaglandin E2 in immortalized human corneal epithelial cells.
Sharif NA; Wiernas TK
J Ocul Pharmacol Ther; 2010 Feb; 26(1):21-9. PubMed ID: 20187806
[TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor inhibits excitatory transmission in rat neostriatum.
Jiang ZG; Yue TL; Feuerstein G
Neurosci Lett; 1993 Jun; 155(2):132-5. PubMed ID: 8104322
[TBL] [Abstract][Full Text] [Related]
39. Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.
Sahu RP
Mol Med Rep; 2015 Jul; 12(1):394-400. PubMed ID: 25695262
[TBL] [Abstract][Full Text] [Related]
40. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line.
Barber LA; Spandau DF; Rathman SC; Murphy RC; Johnson CA; Kelley SW; Hurwitz SA; Travers JB
J Biol Chem; 1998 Jul; 273(30):18891-7. PubMed ID: 9668065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
